Ideaya Biosciences announces research collaboration with Attmos

Ideaya Biosciences (IDYA) announced a research collaboration with Attmos as part of its efforts to build a physics-based computational small molecule discovery platform that unlocks what are currently perceived as undruggable oncology targets. The collaboration will integrate Ideaya’s differentiated and proven capabilities in structural biology and pharmaceutical drug discovery across multiple oncology targets with Attmos’ capabilities in computational chemistry method development, high performance computing, and software development. The focus of the partnership will be to engineer and optimize a workflow solution for high-throughput absolute binding free energy perturbation predictions of drug candidate molecules.